Skip to content

Clinical trials

Completed Hemorrhagic Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhagic Disorders Status: Completed Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20071
20082
20102
20122
20132
20142
20151
20162
20173
20186
20193
20202
20211
20222
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
BioMarin Pharmaceutical5
Swedish Orphan Biovitrum5
Spark Therapeutics, Inc.3
Genzyme, a Sanofi Company2
Novartis Pharmaceuticals2
Seagen Inc.2
AVEO Pharmaceuticals, Inc.1
Astex Pharmaceuticals, Inc.1
Baxalta now part of Shire1
Boston Children's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhagic Disorders34
Blood Coagulation Disorders24
Hematologic Diseases24
Coagulation Protein Disorders16
Genetic Diseases, Inborn15
Hemophilia A15
Blood Coagulation Disorders, Inherited10
Hemostatic Disorders10
Hemophilia B6
Immunoproliferative Disorders6

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.